Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 56 entries
Sorted by: Best Match Show Resources per page
Hypercoagulability in hereditary hemorrhagic telangiectasia with epilepsy.

Journal of neurosciences in rural practice

Finsterer J, Sehnal E.
PMID: 26167029
J Neurosci Rural Pract. 2015 Jul-Sep;6(3):407-9. doi: 10.4103/0976-3147.158791.

Recent data indicate that in patients with hereditary hemorrhagic teleangiectasia (HHT), low iron levels due to inadequate replacement after hemorrhagic iron losses are associated with elevated factor-VIII plasma levels and consecutively increased risk of venous thrombo-embolism. Here, we report...

Cite
Finsterer J, Sehnal E. Hypercoagulability in hereditary hemorrhagic telangiectasia with epilepsy. J Neurosci Rural Pract. 2015;6(3):407-9doi: 10.4103/0976-3147.158791.
Finsterer, J., & Sehnal, E. (2015). Hypercoagulability in hereditary hemorrhagic telangiectasia with epilepsy. Journal of neurosciences in rural practice, 6(3), 407-9. https://doi.org/10.4103/0976-3147.158791
Finsterer, Josef, and Sehnal, Ernst. "Hypercoagulability in hereditary hemorrhagic telangiectasia with epilepsy." Journal of neurosciences in rural practice vol. 6,3 (2015): 407-9. doi: https://doi.org/10.4103/0976-3147.158791
Finsterer J, Sehnal E. Hypercoagulability in hereditary hemorrhagic telangiectasia with epilepsy. J Neurosci Rural Pract. 2015 Jul-Sep;6(3):407-9. doi: 10.4103/0976-3147.158791. PMID: 26167029; PMCID: PMC4481800.
Copy Download .nbib Format: NLM
Inhibition of blood coagulation factors by serine esterase inhibitors.

FEBS letters

De Lange JA, Hemker HC.
PMID: 11946685
FEBS Lett. 1972 Aug 15;24(3):265-268. doi: 10.1016/0014-5793(72)80369-7.

No abstract available.

Cite
De Lange JA, Hemker HC. Inhibition of blood coagulation factors by serine esterase inhibitors. FEBS Lett. 1972;24(3):265-268doi: 10.1016/0014-5793(72)80369-7.
De Lange, J. A., & Hemker, H. C. (1972). Inhibition of blood coagulation factors by serine esterase inhibitors. FEBS letters, 24(3), 265-268. https://doi.org/10.1016/0014-5793(72)80369-7
De Lange, J A., and Hemker, H C.. "Inhibition of blood coagulation factors by serine esterase inhibitors." FEBS letters vol. 24,3 (1972): 265-268. doi: https://doi.org/10.1016/0014-5793(72)80369-7
De Lange JA, Hemker HC. Inhibition of blood coagulation factors by serine esterase inhibitors. FEBS Lett. 1972 Aug 15;24(3):265-268. doi: 10.1016/0014-5793(72)80369-7. PMID: 11946685.
Copy Download .nbib Format: NLM
Blood coagulation factors V and VIII: Molecular Mechanisms of Procofactor Activation.

Journal of coagulation disorders

Bos MH, Camire RM.
PMID: 21165149
J Coagul Disord. 2010 Jul 01;2(2):19-27.

A hallmark of hemostasis is that cells and proteins involved in the formation of a blood clot remain in a quiescent state and are only activated following an appropriate stimulus. The homologous proteins factors V and VIII cannot participate...

Cite
Bos MH, Camire RM. Blood coagulation factors V and VIII: Molecular Mechanisms of Procofactor Activation. J Coagul Disord. 2010;2(2):19-27
Bos, M. H., & Camire, R. M. (2010). Blood coagulation factors V and VIII: Molecular Mechanisms of Procofactor Activation. Journal of coagulation disorders, 2(2), 19-27.
Bos, Mettine H A, and Camire, Rodney M. "Blood coagulation factors V and VIII: Molecular Mechanisms of Procofactor Activation." Journal of coagulation disorders vol. 2,2 (2010): 19-27.
Bos MH, Camire RM. Blood coagulation factors V and VIII: Molecular Mechanisms of Procofactor Activation. J Coagul Disord. 2010 Jul 01;2(2):19-27. PMID: 21165149; PMCID: PMC3001592.
Copy Download .nbib Format: NLM
Hereditary thrombophilic risk factors for recurrent pregnancy loss.

Journal of community genetics

Bogdanova N, Markoff A.
PMID: 22460204
J Community Genet. 2010 Jun;1(2):47-53. doi: 10.1007/s12687-010-0011-3. Epub 2010 Jun 11.

This review summarizes current knowledge about the role of hereditary hypercoagulation factors predisposing to thrombophilia-associated recurrent fetal loss. Thrombophilias are a major cause of adverse pregnancy outcome, playing a role in the etiology of up to 40% of cases...

Cite
Bogdanova N, Markoff A. Hereditary thrombophilic risk factors for recurrent pregnancy loss. J Community Genet. 2010;1(2):47-53doi: 10.1007/s12687-010-0011-3.
Bogdanova, N., & Markoff, A. (2010). Hereditary thrombophilic risk factors for recurrent pregnancy loss. Journal of community genetics, 1(2), 47-53. https://doi.org/10.1007/s12687-010-0011-3
Bogdanova, Nadja, and Markoff, Arseni. "Hereditary thrombophilic risk factors for recurrent pregnancy loss." Journal of community genetics vol. 1,2 (2010): 47-53. doi: https://doi.org/10.1007/s12687-010-0011-3
Bogdanova N, Markoff A. Hereditary thrombophilic risk factors for recurrent pregnancy loss. J Community Genet. 2010 Jun;1(2):47-53. doi: 10.1007/s12687-010-0011-3. Epub 2010 Jun 11. PMID: 22460204; PMCID: PMC3185986.
Copy Download .nbib Format: NLM
Vitamin K: the effect on health beyond coagulation - an overview.

Food & nutrition research

Vermeer C.
PMID: 22489224
Food Nutr Res. 2012;56. doi: 10.3402/fnr.v56i0.5329. Epub 2012 Apr 02.

Vitamin K is essential for the synthesis of proteins belonging to the Gla-protein family. To the members of this family belong four blood coagulation factors, which all are exclusively formed in the liver. The importance of vitamin K for...

Cite
Vermeer C. Vitamin K: the effect on health beyond coagulation - an overview. Food Nutr Res. 2012;56doi: 10.3402/fnr.v56i0.5329.
Vermeer, C. (2012). Vitamin K: the effect on health beyond coagulation - an overview. Food & nutrition research, 56. https://doi.org/10.3402/fnr.v56i0.5329
Vermeer, Cees. "Vitamin K: the effect on health beyond coagulation - an overview." Food & nutrition research vol. 56 (2012). doi: https://doi.org/10.3402/fnr.v56i0.5329
Vermeer C. Vitamin K: the effect on health beyond coagulation - an overview. Food Nutr Res. 2012;56. doi: 10.3402/fnr.v56i0.5329. Epub 2012 Apr 02. PMID: 22489224; PMCID: PMC3321262.
Copy Download .nbib Format: NLM
Blood coagulation induced by Iranian saw-scaled viper (echis carinatus) venom: identification, purification and characterization of a prothrombin activator.

Iranian journal of basic medical sciences

Babaie M, Salmanizadeh H, Zolfagharian H.
PMID: 24494066
Iran J Basic Med Sci. 2013 Nov;16(11):1145-50.

OBJECTIVE(S): Echis carinatus is one of the venomous snakes in Iran. The venom of Iranian Echis carinatus is a rich source of protein with various factors affecting the plasma protein and blood coagulation factor. Some of these proteins exhibit...

Cite
Babaie M, Salmanizadeh H, Zolfagharian H. Blood coagulation induced by Iranian saw-scaled viper (echis carinatus) venom: identification, purification and characterization of a prothrombin activator. Iran J Basic Med Sci. 2013;16(11):1145-50
Babaie, M., Salmanizadeh, H., & Zolfagharian, H. (2013). Blood coagulation induced by Iranian saw-scaled viper (echis carinatus) venom: identification, purification and characterization of a prothrombin activator. Iranian journal of basic medical sciences, 16(11), 1145-50.
Babaie, Mahdi, et al. "Blood coagulation induced by Iranian saw-scaled viper (echis carinatus) venom: identification, purification and characterization of a prothrombin activator." Iranian journal of basic medical sciences vol. 16,11 (2013): 1145-50.
Babaie M, Salmanizadeh H, Zolfagharian H. Blood coagulation induced by Iranian saw-scaled viper (echis carinatus) venom: identification, purification and characterization of a prothrombin activator. Iran J Basic Med Sci. 2013 Nov;16(11):1145-50. PMID: 24494066; PMCID: PMC3909625.
Copy Download .nbib Format: NLM
Evaluation of the plasma quality after filtration.

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences

Mahmoodian Shooshtari M, Mousavi Hosseini K.
PMID: 22615604
Daru. 2010;18(2):114-7.

BACKGROUND AND THE PURPOSE OF THE STUDY: The quality of some of the human plasma derived drugs such as coagulation factor VIII and coagulation factor IX which can be used for the treatment of hemophilia A and B, depends...

Cite
Mahmoodian Shooshtari M, Mousavi Hosseini K. Evaluation of the plasma quality after filtration. Daru. 2010;18(2):114-7
Mahmoodian Shooshtari, M., & Mousavi Hosseini, K. (2010). Evaluation of the plasma quality after filtration. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 18(2), 114-7.
Mahmoodian Shooshtari, M, and Mousavi Hosseini, K. "Evaluation of the plasma quality after filtration." Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences vol. 18,2 (2010): 114-7.
Mahmoodian Shooshtari M, Mousavi Hosseini K. Evaluation of the plasma quality after filtration. Daru. 2010;18(2):114-7. PMID: 22615604; PMCID: PMC3304377.
Copy Download .nbib Format: NLM
Hemostasis in Overt and Subclinical Hyperthyroidism.

International journal of endocrinology and metabolism

Ordookhani A, Burman KD.
PMID: 29201071
Int J Endocrinol Metab. 2017 Apr 23;15(3):e44157. doi: 10.5812/ijem.44157. eCollection 2017 Jul.

CONTEXT: There are contradictory results on the effect of hyperthyroidism on hemostasis. Inadequate population-based studies limited their clinical implications, mainly on the risk of venous thromboembolism (VTE). The present review focuses on hemostatic changes in overt and subclinical hyperthyroidism.METHODS:...

Cite
Ordookhani A, Burman KD. Hemostasis in Overt and Subclinical Hyperthyroidism. Int J Endocrinol Metab. 2017;15(3):e44157doi: 10.5812/ijem.44157.
Ordookhani, A., & Burman, K. D. (2017). Hemostasis in Overt and Subclinical Hyperthyroidism. International journal of endocrinology and metabolism, 15(3), e44157. https://doi.org/10.5812/ijem.44157
Ordookhani, Arash, and Burman, Kenneth D. "Hemostasis in Overt and Subclinical Hyperthyroidism." International journal of endocrinology and metabolism vol. 15,3 (2017): e44157. doi: https://doi.org/10.5812/ijem.44157
Ordookhani A, Burman KD. Hemostasis in Overt and Subclinical Hyperthyroidism. Int J Endocrinol Metab. 2017 Apr 23;15(3):e44157. doi: 10.5812/ijem.44157. eCollection 2017 Jul. PMID: 29201071; PMCID: PMC5702470.
Copy Download .nbib Format: NLM
Hematuria in aging men with hemophilia: Association with factor prophylaxis.

Research and practice in thrombosis and haemostasis

Qvigstad C, Tait RC, de Moerloose P, Holme PA.
PMID: 32110762
Res Pract Thromb Haemost. 2020 Jan 16;4(2):309-317. doi: 10.1002/rth2.12298. eCollection 2020 Feb.

INTRODUCTION: Macroscopic hematuria is considered a significant risk factor for urologic disease, and it is highly prevalent in people with hemophilia.AIM: To determine whether prophylactic factor replacement therapy is associated with reduced occurrence of macroscopic hematuria in people with...

Cite
Qvigstad C, Tait RC, de Moerloose P, et al. Hematuria in aging men with hemophilia: Association with factor prophylaxis. Res Pract Thromb Haemost. 2020;4(2):309-317doi: 10.1002/rth2.12298.
Qvigstad, C., Tait, R. C., de Moerloose, P., Holme, P. A. (2020). Hematuria in aging men with hemophilia: Association with factor prophylaxis. Research and practice in thrombosis and haemostasis, 4(2), 309-317. https://doi.org/10.1002/rth2.12298
Qvigstad, Christian, et al. "Hematuria in aging men with hemophilia: Association with factor prophylaxis." Research and practice in thrombosis and haemostasis vol. 4,2 (2020): 309-317. doi: https://doi.org/10.1002/rth2.12298
Qvigstad C, Tait RC, de Moerloose P, Holme PA. Hematuria in aging men with hemophilia: Association with factor prophylaxis. Res Pract Thromb Haemost. 2020 Jan 16;4(2):309-317. doi: 10.1002/rth2.12298. eCollection 2020 Feb. PMID: 32110762; PMCID: PMC7040553.
Copy Download .nbib Format: NLM
An efficient and effective ambulatory service model for severe hemophilia-A patients; an introduction to a novel home care model.

American journal of blood research

Davari M, Sadeghi A, Gharibnaseri Z, Ravanbod R, Eshghi P, Zargaran M.
PMID: 34824884
Am J Blood Res. 2021 Oct 15;11(5):520-527. eCollection 2021.

INTRODUCTION: Hemophilia A (HA) is an inherited deficiency in blood coagulation factors. Starting the treatment based merely on patients' hemorrhage feelings results in more than 63.6% mistakes in joint bleeding diagnosis. This study aimed to design a useful ambulatory...

Cite
Davari M, Sadeghi A, Gharibnaseri Z, et al. An efficient and effective ambulatory service model for severe hemophilia-A patients; an introduction to a novel home care model. Am J Blood Res. 2021;11(5):520-527
Davari, M., Sadeghi, A., Gharibnaseri, Z., Ravanbod, R., Eshghi, P., & Zargaran, M. (2021). An efficient and effective ambulatory service model for severe hemophilia-A patients; an introduction to a novel home care model. American journal of blood research, 11(5), 520-527.
Davari, Majid, et al. "An efficient and effective ambulatory service model for severe hemophilia-A patients; an introduction to a novel home care model." American journal of blood research vol. 11,5 (2021): 520-527.
Davari M, Sadeghi A, Gharibnaseri Z, Ravanbod R, Eshghi P, Zargaran M. An efficient and effective ambulatory service model for severe hemophilia-A patients; an introduction to a novel home care model. Am J Blood Res. 2021 Oct 15;11(5):520-527. eCollection 2021. PMID: 34824884; PMCID: PMC8610799.
Copy Download .nbib Format: NLM
Clinical utilization of four-factor prothrombin complex concentrate: a retrospective single center study.

Clinical and experimental emergency medicine

Naeem Z, Allan S, Hernandez A, Galanakis DK, Singer AJ.
PMID: 34237811
Clin Exp Emerg Med. 2021 Jun;8(2):75-81. doi: 10.15441/ceem.20.017. Epub 2021 Jun 30.

OBJECTIVE: Four-factor prothrombin complex concentrate (4F-PCC) was approved by the US Food and Drug Administration in 2013 for management of severely bleeding patients on warfarin therapy. We describe use of 4F-PCC at a large, suburban academic center.METHODS: We retrospectively...

Cite
Naeem Z, Allan S, Hernandez A, et al. Clinical utilization of four-factor prothrombin complex concentrate: a retrospective single center study. Clin Exp Emerg Med. 2021;8(2):75-81doi: 10.15441/ceem.20.017.
Naeem, Z., Allan, S., Hernandez, A., Galanakis, D. K., & Singer, A. J. (2021). Clinical utilization of four-factor prothrombin complex concentrate: a retrospective single center study. Clinical and experimental emergency medicine, 8(2), 75-81. https://doi.org/10.15441/ceem.20.017
Naeem, Zaina, et al. "Clinical utilization of four-factor prothrombin complex concentrate: a retrospective single center study." Clinical and experimental emergency medicine vol. 8,2 (2021): 75-81. doi: https://doi.org/10.15441/ceem.20.017
Naeem Z, Allan S, Hernandez A, Galanakis DK, Singer AJ. Clinical utilization of four-factor prothrombin complex concentrate: a retrospective single center study. Clin Exp Emerg Med. 2021 Jun;8(2):75-81. doi: 10.15441/ceem.20.017. Epub 2021 Jun 30. PMID: 34237811; PMCID: PMC8273669.
Copy Download .nbib Format: NLM
Evaluation of selected parameters of the coagulation system during the perioperative period in patients undergoing endoscopic surgery of the paranasal sinuses.

Archives of medical science : AMS

Urbaniak J, Owczarek K, Miłoński J, Pietkiewicz P, Jałocha-Kaczka A, Olszewski J.
PMID: 33224332
Arch Med Sci. 2018 Jan 04;16(6):1336-1345. doi: 10.5114/aoms.2017.72544. eCollection 2020.

INTRODUCTION: The aim of the study was to evaluate selected parameters of the coagulation system during the perioperative period in patients undergoing endoscopic sinus surgery.MATERIAL AND METHODS: The study involved 121 patients: group I - 42 patients who did...

Cite
Urbaniak J, Owczarek K, Miłoński J, et al. Evaluation of selected parameters of the coagulation system during the perioperative period in patients undergoing endoscopic surgery of the paranasal sinuses. Arch Med Sci. 2018;16(6):1336-1345doi: 10.5114/aoms.2017.72544.
Urbaniak, J., Owczarek, K., Miłoński, J., Pietkiewicz, P., Jałocha-Kaczka, A., & Olszewski, J. (2020). Evaluation of selected parameters of the coagulation system during the perioperative period in patients undergoing endoscopic surgery of the paranasal sinuses. Archives of medical science : AMS, 16(6), 1336-1345. https://doi.org/10.5114/aoms.2017.72544
Urbaniak, Joanna, et al. "Evaluation of selected parameters of the coagulation system during the perioperative period in patients undergoing endoscopic surgery of the paranasal sinuses." Archives of medical science : AMS vol. 16,6 (2020): 1336-1345. doi: https://doi.org/10.5114/aoms.2017.72544
Urbaniak J, Owczarek K, Miłoński J, Pietkiewicz P, Jałocha-Kaczka A, Olszewski J. Evaluation of selected parameters of the coagulation system during the perioperative period in patients undergoing endoscopic surgery of the paranasal sinuses. Arch Med Sci. 2018 Jan 04;16(6):1336-1345. doi: 10.5114/aoms.2017.72544. eCollection 2020. PMID: 33224332; PMCID: PMC7667416.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 56 entries